Nuformix Plc Announces £300K Fundraising Effort
Company Announcements

Nuformix Plc Announces £300K Fundraising Effort

Nuformix Plc (GB:NFX) has released an update.

Nuformix plc, a pharmaceutical company focused on fibrosis and oncology, has announced a fundraise of £300,000 through the issuance of 600 million new shares at a discount. The proceeds will primarily advance their NXP002 program for treating fibrotic lung diseases, alongside general corporate funding. The fundraising is conditional upon regulatory approvals and shareholder consent, with a planned capital reorganisation to accommodate the new shares’ issue price.

For further insights into GB:NFX stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskNuformix Directors Boost Stake in Fundraising Effort
TipRanks UK Auto-Generated NewsdeskNuformix Approves New Shares, Eyes Growth in Market
TipRanks UK Auto-Generated NewsdeskNuformix Announces Major Fundraising and Share Issuance
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App